Edition:
United Kingdom

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

6.05USD
8:59pm GMT
Change (% chg)

$0.15 (+2.54%)
Prev Close
$5.90
Open
$5.95
Day's High
$6.10
Day's Low
$5.95
Volume
41,683
Avg. Vol
20,017
52-wk High
$7.05
52-wk Low
$3.35

Chart for

About

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads... (more)

Overall

Beta: -0.59
Market Cap(Mil.): $173.02
Shares Outstanding(Mil.): 28.13
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Cytosorbents posts Q3 revenue of $3.8 mln

* Cytosorbents continues strong trajectory of growth in the third quarter 2017

09 Nov 2017

BRIEF-CytoSorbents says partnered with DRGR to expand sales, distribution of cytosorb to Panama

* CytoSorbents says partnered with Droguería Ramón González Revilla (DRGR) to expand sales and distribution of cytosorb to panama

17 Jul 2017

BRIEF-CytoSorbents receives additional $5 mln in non-dilutive debt financing from Bridge Bank

* CytoSorbents receives additional $5 million in non-dilutive debt financing from Bridge Bank

05 Jul 2017

Competitors

Earnings vs. Estimates